BioTissue Holdings Inc. FDA Inspection Record
BioTissue Holdings Inc. is an FDA-registered facility (FEI 3009809074) located in Doral, FL, US. RegDataLab tracks 11 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Sep 1, 2026: Official Action Indicated (OAI)
- Inspections on record
- 11 (1 OAI, 4 VAI, 6 NAI)
- Last OAI inspection
- Sep 1, 2026
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 2, latest Oct 20, 2023
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 1, 2026 | Official Action Indicated (OAI) | No citations listed |
| Feb 18, 2026 | Voluntary Action Indicated (VAI) | Information gathered in feedback process not used as input into risk management (ISO 13485:2016 Clause 8.2.1) Corrective action not taken (ISO 13485:2016 Clause 8.5.2) Report of Death or Serious Injury (21 CFR 803.50(a)(1)) |
| Mar 6, 2024 | Voluntary Action Indicated (VAI) | Investigation of device failures (21 CFR 820.198(c)) Documentation (21 CFR 820.100(b)) Report of Death or Serious Injury (21 CFR 803.50(a)(1)) Individual Report of Malfunction (21 CFR 803.50(a)(2)) |
| Aug 15, 2019 | No Action Indicated (NAI) | No citations listed |
| Jul 16, 2019 | Voluntary Action Indicated (VAI) | Procedures not adequately established or maintained (21 CFR 820.40) Lack of or inadequate procedures (21 CFR 820.100(a)) Product rework procedures, Lack of or inadequate procedures (21 CFR 820.90(b)(2)) Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a)) and 1 more |
| Feb 6, 2018 | Voluntary Action Indicated (VAI) | Testing, screening, donor eligibility procedures (21 CFR 1271.47(a)) Risk factors, clinical evidence (21 CFR 1271.75(a)(1)) Documentation of activities (21 CFR 1271.190(d)(2)) Corrective actions (21 CFR 1271.195(b)) and 7 more |
| Oct 29, 2015 | No Action Indicated (NAI) | No citations listed |
| Jul 7, 2015 | No Action Indicated (NAI) | No citations listed |
| Sep 25, 2014 | No Action Indicated (NAI) | No citations listed |
| Dec 9, 2013 | No Action Indicated (NAI) | Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 20, 2023 | Class II | B-0372-2024 | Amniotic Membrane Human tissue allografts, which did not meet release criteria designed to prevent communicable disease transmission, were distributed. |
| Nov 10, 2020 | Class II | Z-0550-2021 | PROKERA, non-sterile - Product Usage: Biologic corneal bandage. and 2 more products Potential exposure of product to microbial contamination. |
FDA record score
45 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
7 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified OAI | Sep 1, 2026 | 30 x 1 | 30 |
| Inspection classified VAI | Feb 18, 2026 | 6 x 1 | 6 |
| Inspection classified VAI | Mar 6, 2024 | 6 x 0.6 | 3.6 |
| Class II recall B-0372-2024, this FEI as the recalling firm | Oct 20, 2023 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jul 16, 2019 | 6 x 0.25 | 1.5 |
| Class II recall Z-0550-2021, this FEI as the recalling firm | Nov 10, 2020 | 4 x 0.25 | 1 |
| Inspection classified VAI | Feb 6, 2018 | Only the 3 most recent VAI inspections add points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing BioTissue Holdings Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check BioTissue Holdings Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- BioTissue Holdings Inc
- Location
- Doral, FL (US)
- Source
- device